In January 2025, the Minister of Human Resources and Social Development issued a resolution to implement Saudization rates for pharmacy professionals. Under the scheme, private establishments operating in the Kingdom that employ 5 or more workers will have the obligation […]
Vision 2030 sets an ambitious plan to localize medicines and vaccines in Saudi Arabia. Where are we on this ambition? From the official list that we can find on the Local Content & Government Procurement Authority, there are 192 medicines
We saw in our recent articles that supply chain disruptions force countries to redefine their sovereignty policies in pharma. Policies have paved the way for local and global players to establish partnerships, such as Vision 2030 in Saudi Arabia. Last
The Public Investment Fund (PIF) has established its Vision 2030 to enable Saudi Arabia’s private sector to find new investment opportunities, both domestically and internationally. How does Vision 2030 affect the kingdom’s pharma strategy? The Saudi Public Investment Fund (PIF)
103 years after its discovery, insulin is reinventing itself: from pricing readjustments in major markets to the increasing usage of biosimilars. Historic players like Novo Nordisk and Eli Lilly seek growth outside insulin, with successes notably in obesity management drugs
